Over the past two decades, the pharmaceutical industry has moved very far from its original high purpose of discovering and producing useful new drugs. Now primarily a marketing machine to sell drugs of dubious benefit, this industry uses its wealth and power to co-opt every institution that might stand in its way, including the US Congress, the FDA, academic medical centres, and the medical profession itself.
Hence here we are with an extra-ordinary personality Sanjeev Kumar Gupta, Director, TELPHACARE
Tell us about TELPHACARE. Its vision and mission.
Our Mission : “To be an organization providing complete marketing services of health care therapies for a better quality of life”.
Our Vision : “To be a global Pharmaceutical company with a focus on innovative marketing of speciality pharmaceuticals”.
What were the constraints you faced at the time of inception?
Arranging planned funds from the bank, ensuring compliance from third party manufacturers were amongst the key constraints.
What unique services do you provide to the customers? Why should one prefer you?
A complete basket of products from acute to chronic segments disease prevention and treatment is being provided to our customers at their doorstep through our distribution team alongside a very competent sales and marketing team promoting products with requisite information and data supported by an in-house IT Team.
What personality traits and capabilities do you believe are required to enhance and promote health solution providing services?
- A trained marketing department capable of concentrating, on the generation of prescriptions by a doctor.
- A well-integrated IT-supported Distribution department to ensure encashment of prescriptions at the trade-channels primarily at the chemist is the major link.
- An online portal to support chemist and end-user (patient) catering to the prescriptions.
- HR Department to focus on Human Psychology as behaviours are particularly important, a working culture of an employee in one country is different from another country.
- Development of local resources at ground level to reflect as that countrys’ national company – building a sense of localized preference.
- Provide autonomy in making operational decisions keeping in mind the goals to be achieved.
Share about your journey from the beginning
- 2008 – Incorporation of Telpha INC in Cambodia. As per Cambodia Laws
- 2009 – Incorporation of Acventa Research Labs (Controlling Stakes), Started on Shore operations in Cambodia (Telpha Inc)
- 2010 – Initiated Myanmar Operations
- 2012 – Alliance in Vietnam
- 2013 – Registered Telphacare India as a proprietor company to set up a base in India.
- 2015 – Joint Venture with Eseptlogic Technologies Pvt Ltd and incorporation of Aqvira Technologies India to support IT operations of Telpha.
- 2017 – Incorporation of Telphacare India Pvt Limited to take over operations of Telphacare.
- 2018 – Incorporation of VIBGYOR Technologies Cambodia to support IT infrastructure of Telpha operations in Cambodia and Myanmar.
- 2019 – Joint venture with Heng Heng Impex in Cambodia.
How do you manage the promotion of your project through social media outreach and email campaigns?
We do not endorse social media management or email campaigns.
What do you think about the expansion of TELPHACARE? What will be the plan?
In the short, to medium term, Telphacare India is poised to set up footprints in manufacturing in the Nutraceuticals and Health Supplements sector to start with before moving to set up a pharmaceutical manufacturing base in the medium to long term.
To strengthen its international operation, TIPL wishes to expedite onshore operations in the Philippines which were delayed due to COVID-19 and forge alliances in nutraceutical segments in Mexico.
How do you see the future of healthcare in nearby times?
With millions cases and deaths, India is among the nations hardest hit by the corona virus pandemic. The Asian giant has also taken an economic hit, its gross domestic product expected to shrink 8 per cent this year. India needs to overhaul and improve health care say today’s difficult times create a moment of opportunity because people who often don’t listen to each other out are now listening. As for the first time in 30 years GDP is has fallen in response to a health crisis.
Most of us view the current publicly-funded system as so bad that even the poorest Indians would rather pay out-of-pocket for care in a network of private providers, itself sometimes seen as uncaring and untrustworthy. The result is that more than 60 per cent of Indian health care is paid for out-of-pocket, and a sudden illness can mean financial ruin for people at large. Only the wealthy can afford regular, high-quality care.
We should seek input from an array of stakeholders, including representatives of the private health care sector, providers of traditional medicine, physicians, community health workers, and citizens from diverse communities across the country and thereby architecture a new system, which should include ways to provide preventive care for physical and mental health, offer financial protection for all health care costs, not just hospitalization, and ensure access to the same quality of care for all and a health care system in which most people do not pay out-of-pocket for most health care needs.
In the next, two to three years through optimization of existing structures govern financials are constrained due to pandemic.
Can you describe emerging trends you noticed HEALTHCARE industry?
The COVID-19 pandemic accelerated the adoption of telemedicine by many governments, healthcare systems, clinicians, and patients. To tackle the pandemic, governments issued telemedicine guidelines to decongest healthcare facilities. This minimizes the load on facilities and reduces the use of personal protective equipment (PPE) as medical practitioners reach their patients via telecommunication. Moreover, telehealth services facilitate public health mitigation strategies by increasing social distancing. Telemedicine also aids to assist elderly people remotely, reduces bed space, and conserves clinical supplies.
Mobile Health (M Health)
Mobile health technologies provide access to personalized information using digital solutions and connected devices. Mobile devices enable visualization of health issues that prevent patient commitment. Unconstrained by geographical boundaries and using real-time data streams, Smartphone-linked wearable sensors, point-of-need diagnostic devices, and medical-grade imaging make healthcare delivery more equitable and accessible. mHealth solutions played a critical role in controlling the spread of the COVID-19 pandemic by enabling contact tracing, surveillance, quarantine control and management, testing, and dissemination of relevant information, as well as immunization cycle tracking and notification.
There have been notable efforts in developing genomics tools for various applications in recent times. Integration of both genomic knowledge and genomic processes into existing clinical workflows would ensure physicians perform established communication and actionable recommendations that a genomic test can provide to patients. The new arena of personalized medicine is possible due to the advent of innovations in genomics. Gene therapy and gene-based therapy solutions have revolutionized clinical medicine and speciality care for several unmet clinical needs.
3D printing is gaining traction in the healthcare industry for multiple applications like printing lightweight prosthetics, bionics, and casts for fracture repair. The use of inexpensive, lightweight biomaterials and smart materials ensures improvement in care delivery and time of production while reducing costs. 3D printing technologies are advancing the development of patient-specific models of organs and surgical tools, using the patient’s medical imaging. Another area of application includes personalized surgical instruments that increase a surgeon’s dexterity and support better surgery outcomes while facilitating faster and less traumatic procedures.
Please tell us if there is an effective solution to the current COVID19 scenario?
The accessibility of a safe and effective vaccine for COVID-19 is an inevitable effective solution to the control of Covid 19.
TIPL is a progressive organization based in Delhi with the sole objective of sourcing/ trading /developing pharmaceutical and health care products for sales distribution marketing through its alliances/subsidiaries/ business partners in India and abroad predominantly in the Southeast Asia region
The Board of Management comprises a team of personalities who have a collective experience of 60 years in the Indian and International pharma industry by the virtue of their career path works in various geographies around the globe.
Incorporated in 2008 in India – the organization basic function is sourcing the pharmaceutical & health care product needs for its alliances /subsidiaries and business partners in India and Abroad. You may refer to the webpage for further details which will give you a proper insight into the operations of various divisions.
Standalone TIPL captures a turnover of appx 300lac in 2021-22, but its overseas operations in countries like Myanmar and Cambodia (where the directors of TIPL have investments), are significant.
Telpha Inc, Cambodia is one of the top 15 Pharmaceutical marketing and distribution organizations established in 2008 with an annual turnover of USD 7.5 million in 2020 with a YOY growth of 20%.
Our operations in Myanmar, Telpha have a progressive pharmaceutical distribution and marketing alliance established in 2014 with an annual turnover of USD 2.5 million in 2020 with YOY growth of 20%.
Since 2017 as a part of the growth strategy for TIPL – we have pursued the sourcing strategy outside our alliance’s companies. In this way, we got registered ourselves as suppliers for UNOPS (www.unops.org), an organization working as an integral member of the United Nations.
|Year of Founding||2008|
|Founding Information||Telphacare India Private Limited is a Private incorporated on 11 May 2017. It is classified as a non-govt company and is registered at Registrar of Companies, Delhi. Its authorized share capital is Rs. 2,500,000.|
|Founding Members:||Directors of Telphacare India Private Limited are Sanjeev Kumar Gupta, Sangita Gupta and Pundari Baba Vallabhaneni.|
|Office Locations||Delhi, Cambodia, Myanmar|